Squarepoint’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$918K Buy
+114,273
New +$1.1M ﹤0.01% 2839
2025
Q4
Sell
-35,856
Closed -$360K 4857
2025
Q3
$360K Buy
+35,856
New +$515K ﹤0.01% 3523
2025
Q2
Sell
-76,824
Closed -$966K 5019
2025
Q1
$966K Buy
76,824
+52,047
+210% +$626K ﹤0.01% 2699
2024
Q4
$261K Sell
24,777
-9,204
-27% -$129K ﹤0.01% 4256
2024
Q3
$493K Buy
+33,981
New +$404K ﹤0.01% 3108
2023
Q3
Sell
-84,808
Closed -$568K 4216
2023
Q2
$568K Buy
84,808
+71,905
+557% +$480K ﹤0.01% 2547
2023
Q1
$84K Buy
+12,903
New +$99.1K ﹤0.01% 3002
2021
Q4
Sell
-15,593
Closed -$156K 3498
2021
Q3
$156K Buy
15,593
+6,492
+71% +$160K ﹤0.01% 2581
2021
Q2
$281K Buy
+9,101
New +$292K ﹤0.01% 2587

Other funds holding SPRY